Filing Details
- Accession Number:
- 0000711377-11-000053
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-11-04 11:57:39
- Reporting Period:
- 2011-11-03
- Filing Date:
- 2011-11-04
- Accepted Time:
- 2011-11-04 11:57:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 711377 | Neogen Corp | NEOG | In Vitro & In Vivo Diagnostic Substances (2835) | 382367843 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1189021 | Edward Bradley | Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-11-03 | 5,850 | $9.02 | 115,371 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-11-03 | 5,850 | $38.71 | 109,521 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock (Right to Buy) | Disposition | 2011-11-03 | 5,850 | $0.00 | 5,850 | $9.02 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 99,509 | 2011-11-03 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 14,012 | Indirect | Held in trust by Neogen 401k plan |
Footnotes
- Optins were granted 11/3/2006 and vested 20% annually each year for five years
Billionaire Hedge Funds
